For more than a year, The American Legion has been calling on the federal government – and specifically the Veterans Affairs Department – to support research into the therapeutic benefits of cannabis in treating veterans with PTSD.
Many veterans, especially Iraq and Afghanistan combat veterans, have told both the Legion and NORML that they have been able to eliminate or reduce their dependency on other drugs, specifical opioids.
Now, the Legion is ramping up their efforts to convince VA Secretary Shulkin to expand research into the therapeutic and medicinal effects of cannabis.
In a letter sent yesterday and released publicly today, they state:
This comes just one month after the Legion adopted a resolution calling on federal officials to expand veterans’ access to medical marijuana.
NORML has documented the longitudinal data on how cannabis access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, and opioid-related overdose deaths
You can read the full letter to VA urging cannabis research access here.
Earlier this year, a budget amendment that reflected the Veterans Equal Access Act’s language was introduced by Senator Daines (R-MT) and passed in the Senate Appropriations Committee and introduced by Rep. Blumenauer and blocked in the House Rules Committee. The amendments fate will likely be decided in a joint conference committee later this year.